Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Miljenko Zuanic	3/8/2005 7:27:53 PM
	Read Replies (1) of 3044

Love when analysts in their "analysis" compare apples to potatoes. Confirm my overall view that they should stick fingers in their asses and sing..."kukuriku!" Miljenko Associated Press Millennium Shares Slip on Downgrade Tuesday March 8, 4:09 pm ET Millennium Shares Slide After Analyst Predicts Celgene Cancer Treatment Will Pressure Sales NEW YORK (AP) -- Shares of Millennium Pharmaceuticals Inc. edged lower Tuesday after an investment bank predicted that Celgene Corp.'s experimental treatment for multiple myeloma -- a cancer of the blood -- will cut into sales of Millennium's Velcade drug by the end of 2005.... Meacham wrote in a research note that while the multiple myeloma market is large enough for Velcade and Thalomid, "we expect that Revlimid with superior efficacy and likely a superior safety profile could quickly become the standard of care" for relapsed, drug-resistant multiple myeloma.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next